Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 7/20 | 0.53 |
| ▸ | BCHE known ✓ | P06276 | 2/20 | 0.53 |
| ▸ | ACHE known ✓ | P22303 | 2/20 | 0.53 |
| ▸ | MAOA known ✓ | P21397 | 1/20 | 0.53 |
| ▸ | PTGS1 known ✓ | P23219 | 1/20 | 0.53 |
| ▸ | SLC6A2 known ✓ | P23975 | 1/20 | 0.53 |
| ▸ | HTR2C known ✓ | P28335 | 1/20 | 0.53 |
| ▸ | PTGS2 known ✓ | P35354 | 1/20 | 0.53 |
| ▸ | SLC6A3 known ✓ | Q01959 | 1/20 | 0.53 |
| ▸ | NOX1 | Q9Y5S8 | 11/20 | 0.53 |
| ▸ | MAPT | P10636 | 8/20 | 0.53 |
| ▸ | MEN1 | O00255 | 4/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | SNCA | P37840 | 2/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL20994584 | 1.00 | NOX1 (0.53) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL26797 | 0.98 | NOX1 (0.55) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL29379406 | 0.98 | NOX1 (0.55) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL10876335 | 0.90 | NOX1 (0.50) | NOX1MAPTGAAMEN1KMT2A | |
| Indole SCHEMBL29005716 | 0.85 | TRPA1 (0.46) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL28379797 | 0.81 | NOX1 (0.52) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL30005581 | 0.81 | NOX1 (0.52) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL31086276 | 0.81 | NOX1 (0.47) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL18165216 | 0.79 | MAPT (0.59) | NOX1MAPTGAAMEN1KMT2A | |
| SCHEMBL20444678 | 0.79 | NOX1 (0.45) | NOX1MAPTGAAMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230149546-A1 | PHOTOSENSITIZER CONJUGATED GOLD NANOPARTICLES FOR RADIOTHERAPY ENHANCEMENT | BIOVENTURES, LLC | 2023-05-18 | — | — | US | claimed |
| WO-2021211975-A1 | PHOTOSENSITIZER CONJUGATED NANOPARTICLES FOR RADIOTHERAPY ENHANCEMENT | BIOVENTURES, LLC (US) | 2021-10-21 | — | — | WO | claimed |
| US-10874107-B2 | β-lactamase targeted photosensitizer for pesticide and pest detection | THE GENERAL HOSPITAL CORPORATION (US) | 2020-12-29 | — | — | US | claimed |
| US-10646570-B2 | Induced photodynamic therapy using nanoparticle scintillators as transducers | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2020-05-12 | — | — | US | claimed |
| EP-3157337-B1 | INDUCED PHOTODYNAMIC THERAPY USING NANOPARTICLE SCINTILLATORS AS TRANSDUCERS | UNIV GEORGIA (US) | 2019-05-29 | — | — | EP | claimed |
| US-20180094292-A1 | Photoactivatable Antimicrobial Agents And Therapeutic And Diagnostic Methods Of Using Same | THE GENERAL HOSPITAL CORPORATION | 2018-04-05 | — | — | US | claimed |
| US-9828622-B2 | Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same | THE GENERAL HOSPITAL CORPORATION (US) | 2017-11-28 | — | — | US | claimed |
| US-20170209575-A1 | INDUCED PHOTODYNAMIC THERAPY USING NANOPARTICLE SCINTILLATORS AS TRANSDUCERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-07-27 | — | — | US | claimed |
| EP-3157337-A2 | INDUCED PHOTODYNAMIC THERAPY USING NANOPARTICLE SCINTILLATORS AS TRANSDUCERS | University of Georgia Research Foundation Inc. (US) | 2017-04-26 | — | — | EP | claimed |
| US-20160073634-A1 | BETA-LACTAMASE TARGETED PHOTOSENSITIZER FOR PESTICIDE AND PEST DETECTION | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2016-03-17 | — | — | US | claimed |
| WO-2015195889-A2 | INDUCED PHOTODYNAMIC THERAPY USING NANOPARTICLE SCINTILLATORS AS TRANSDUCERS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2015-12-23 | — | — | WO | claimed |
| EP-2285381-B1 | PHOTOACTIVATABLE BETA-LACTAMASE SUBSTRATES AND ANALYTICAL METHODS OF USING SAME | GEN HOSPITAL CORP (US) | 2015-12-16 | — | — | EP | claimed |
| WO-2013192521-A1 | β-LACTAMASE TARGETED PHOTOSENSITIZER FOR PESTICIDE AND PEST DETECTION | THE GENERAL HOSPITAL CORPORATION (US) | 2013-12-27 | — | — | WO | claimed |
| US-20110112059-A1 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS AND THERAPEUTIC AND DIAGNOSTIC METHODS OF USING SAME | THE GENERAL HOSPITAL CORPORATION (US) | 2011-05-12 | — | — | US | claimed |
| EP-2285381-A2 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS AND THERAPEUTIC AND DIAGNOSTIC METHODS OF USING SAME | The General Hospital Corporation (US) | 2011-02-23 | — | — | EP | claimed |
| US-20100016208-A1 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS | THE GENERAL HOSPITAL CORPORATION (US) | 2010-01-21 | — | — | US | claimed |
| WO-2009137062-A2 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS AND THERAPEUTIC AND DIAGNOSTIC METHODS OF USING SAME | THE GENERAL HOSPITAL CORPORATION (US) | 2009-11-12 | — | — | WO | claimed |
| EP-1962833-A2 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS | THE GENERAL HOSPITAL CORPORATION (US) | 2008-09-03 | — | — | EP | claimed |
| WO-2007059226-A2 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS | THE GENERAL HOSPITAL CORPORATION (US) | 2007-05-24 | — | — | WO | claimed |
| WO-2024175997-A2 | WATER-SOLUBLE CHLOROPHYLL PROTEIN AS EFFICIENT PHOTOSENSITIZER FOR CANCER PHOTODYNAMIC THERAPY | THE HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY (CN) | 2024-08-29 | — | — | WO | disclosed |
| US-11795491-B2 | Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same | THE GENERAL HOSPITAL CORPORATION (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230149546-A1 | PHOTOSENSITIZER CONJUGATED GOLD NANOPARTICLES FOR RADIOTHERAPY ENHANCEMENT | BIOVENTURES, LLC | 2023-05-18 | — | — | US | disclosed |
| WO-2021211975-A1 | PHOTOSENSITIZER CONJUGATED NANOPARTICLES FOR RADIOTHERAPY ENHANCEMENT | BIOVENTURES, LLC (US) | 2021-10-21 | — | — | WO | disclosed |
| US-10874107-B2 | β-lactamase targeted photosensitizer for pesticide and pest detection | THE GENERAL HOSPITAL CORPORATION (US) | 2020-12-29 | — | — | US | disclosed |
| US-20200154710-A1 | BETA-LACTAMASE TARGETED PHOTOSENSITIZER FOR PESTICIDE AND PEST DETECTION | BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT | 2020-05-21 | — | — | US | disclosed |
| US-10646570-B2 | Induced photodynamic therapy using nanoparticle scintillators as transducers | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2020-05-12 | — | — | US | disclosed |
| EP-3157337-B1 | INDUCED PHOTODYNAMIC THERAPY USING NANOPARTICLE SCINTILLATORS AS TRANSDUCERS | UNIV GEORGIA (US) | 2019-05-29 | — | — | EP | disclosed |
| EP-3056497-B1 | METHODS USING BODIPY-LABELLED ENZYME SUBSTRATES | MASSACHUSETTS GEN HOSPITAL (US) | 2018-08-29 | — | — | EP | disclosed |
| US-20180094292-A1 | Photoactivatable Antimicrobial Agents And Therapeutic And Diagnostic Methods Of Using Same | THE GENERAL HOSPITAL CORPORATION | 2018-04-05 | — | — | US | disclosed |
| US-9828622-B2 | Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same | THE GENERAL HOSPITAL CORPORATION (US) | 2017-11-28 | — | — | US | disclosed |
| US-20170209575-A1 | INDUCED PHOTODYNAMIC THERAPY USING NANOPARTICLE SCINTILLATORS AS TRANSDUCERS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-07-27 | — | — | US | disclosed |
| EP-3157337-A2 | INDUCED PHOTODYNAMIC THERAPY USING NANOPARTICLE SCINTILLATORS AS TRANSDUCERS | University of Georgia Research Foundation Inc. (US) | 2017-04-26 | — | — | EP | disclosed |
| EP-3056497-A1 | BODIPY-LABELLED ENZYME SUBSTRATES AND METHODS USING THEM | The General Hospital Corporation (US) | 2016-08-17 | — | — | EP | disclosed |
| US-20160073634-A1 | BETA-LACTAMASE TARGETED PHOTOSENSITIZER FOR PESTICIDE AND PEST DETECTION | NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR | 2016-03-17 | — | — | US | disclosed |
| WO-2015195889-A2 | INDUCED PHOTODYNAMIC THERAPY USING NANOPARTICLE SCINTILLATORS AS TRANSDUCERS | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2015-12-23 | — | — | WO | disclosed |
| EP-2285381-B1 | PHOTOACTIVATABLE BETA-LACTAMASE SUBSTRATES AND ANALYTICAL METHODS OF USING SAME | GEN HOSPITAL CORP (US) | 2015-12-16 | — | — | EP | disclosed |
| WO-2013192521-A1 | β-LACTAMASE TARGETED PHOTOSENSITIZER FOR PESTICIDE AND PEST DETECTION | THE GENERAL HOSPITAL CORPORATION (US) | 2013-12-27 | — | — | WO | disclosed |
| US-20110112059-A1 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS AND THERAPEUTIC AND DIAGNOSTIC METHODS OF USING SAME | THE GENERAL HOSPITAL CORPORATION (US) | 2011-05-12 | — | — | US | disclosed |
| EP-2285381-A2 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS AND THERAPEUTIC AND DIAGNOSTIC METHODS OF USING SAME | The General Hospital Corporation (US) | 2011-02-23 | — | — | EP | disclosed |
| US-20100016208-A1 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS | THE GENERAL HOSPITAL CORPORATION (US) | 2010-01-21 | — | — | US | disclosed |
| WO-2009137062-A2 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS AND THERAPEUTIC AND DIAGNOSTIC METHODS OF USING SAME | THE GENERAL HOSPITAL CORPORATION (US) | 2009-11-12 | — | — | WO | disclosed |
| US-20090259167-A1 | METHODS AND COMPOSITIONS FOR DOSE-DEPENDENT PHOTODYNAMIC THERAPY OF DISORDERS | THE GENERAL HOSPITAL CORPORATION (US) | 2009-10-15 | — | — | US | disclosed |
| EP-1962833-A2 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS | THE GENERAL HOSPITAL CORPORATION (US) | 2008-09-03 | — | — | EP | disclosed |
| WO-2007059226-A2 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS | THE GENERAL HOSPITAL CORPORATION (US) | 2007-05-24 | — | — | WO | disclosed |
| WO-2007059226-A2 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS | THE GENERAL HOSPITAL CORPORATION (US) | 2007-05-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10874107-B2 | β-lactamase targeted photosensitizer for pesticide and pest detection | DDT, BCHE, GUSB | GAA 19/4885BCHE 2/4885ACHE 10/4885 |
| US-20160073634-A1 | BETA-LACTAMASE TARGETED PHOTOSENSITIZER FOR PESTICIDE AND PEST DETECTION | DDT, BCHE, GUSB | GAA 21/4885BCHE 2/4885ACHE 8/4885 |
| US-20100016208-A1 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS | CRY1, HMBS, PPOX | GAA 181/4885BCHE 2260/4885ACHE 3843/4885 |
| US-20180094292-A1 | Photoactivatable Antimicrobial Agents And Therapeutic And Diagnostic Methods Of Using Same | HMBS, GUSB, LCT | GAA 4/4885BCHE 51/4885ACHE 170/4885 |
| US-11795491-B2 | Photoactivatable antimicrobial agents and therapeutic and diagnostic methods of using same | HMBS, GUSB, LCT | GAA 4/4885BCHE 51/4885ACHE 170/4885 |
| US-20110112059-A1 | PHOTOACTIVATABLE ANTIMICROBIAL AGENTS AND THERAPEUTIC AND DIAGNOSTIC METHODS OF USING SAME | HMBS, GUSB, LCT | GAA 4/4885BCHE 51/4885ACHE 170/4885 |
| US-20200154710-A1 | BETA-LACTAMASE TARGETED PHOTOSENSITIZER FOR PESTICIDE AND PEST DETECTION | DDT, BCHE, GUSB | GAA 21/4885BCHE 2/4885ACHE 8/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.